Liquidia Corporation Common Stock vs W.R. Berkley Corporation Common Stock — how do they compare? Liquidia Corporation Common Stock trades at $33.46 (market cap $2.40B), while W.R. Berkley Corporation Common Stock trades at $74.25 (market cap $27.30B). The key difference: W.R. Berkley Corporation Common Stock is far larger — about 11.4× Liquidia Corporation Common Stock's market cap, and W.R. Berkley Corporation Common Stock pays a 0.54% dividend while Liquidia Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and W.R. Berkley Corporation Common Stock for 0 Days on average.
| LQDA | WRB | |
|---|---|---|
Market Cap | $2.40B | $27.30B |
Volume | 2,857,547 | 2,293,079 |
Sector | Health | Financials |
52-Week High | $91.03 | $78.10 |
52-Week Low | $22.02 | $63.54 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.30B | $27.54B |
Dividend Yield | — | 0.54% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →W.R. Berkley Corporation is an insurance holding company that underwrites commercial property and casualty insurance and reinsurance through its Insurance and Reinsurance & Monoline Excess segments.
Read more on WRB →